The non-canonical target PARP16 contributes to polypharmacology of the PARP inhibitor talazoparib and its synergy with WEE1 inhibitors
Autor: | Palve, Vinayak, Knezevic, Claire E., Bejan, Daniel S., Luo, Yunting, Li, Xueli, Novakova, Silvia, Welsh, Eric A., Fang, Bin, Kinose, Fumi, Haura, Eric B., Monteiro, Alvaro N., Koomen, John M., Cohen, Michael S., Lawrence, Harshani R., Rix, Uwe |
---|---|
Zdroj: | In Cell Chemical Biology 17 February 2022 29(2):202-214 |
Databáze: | ScienceDirect |
Externí odkaz: |